Gabapentin activates ROMK1 channels by a protein kinase A (PKA)-dependent mechanism

British Journal of Pharmacology

Volumn 154, Issue 1, 2008, Pages 216-225

  Lee, C H ^a   Tsai, T S ^a   Liou, H H ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Epilepsy; Gabapentin; PKA; ROMK1 channels

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GABAPENTIN; KT 5720; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; KIDNEY MEDULLA; NONHUMAN; OOCYTE; PATCH CLAMP; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; XENOPUS LAEVIS;

EID: 42949138261     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.73     Document Type: Article

References (47)

1. Angehagen M, Ronnback L, Hansson E, Ben‐Menachem E (2005). Topiramate reduces AMPA‐induced Ca 2+ transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J Neurochem 94: 1124–1130.
2. Bertrand S, Morin F, Lacaille JC (2003a). Different actions of gabapentin and baclofen in hippocampus from weaver mice. Hippocampus 13: 525–528.
3. Bertrand S, Nouel D, Morin F, Nagy F, Lacaille JC (2003b). Gabapentin actions on Kir3 currents and N‐type Ca 2+ channels via GABA B receptors in hippocampal pyramidal cells. Synapse 50: 95–109.
4. Fakler B, Schultz JH, Yang J, Schulte U, Brandle U, Zenner HP et al. (1996). Identification of a titratable lysine residue that determines sensitivity of kidney potassium channels (ROMK) to intracellular pH. EMBO J 15: 4093–4099.
5. Fan Z, Makielski JC (1997). Anionic phospholipids activate ATP‐sensitive potassium channels. J Biol Chem 272: 5388–5395.
6. Freiman TM, Kukolja J, Heinemeyer J, Eckhardt K, Aranda H, Rominger A et al. (2001). Modulation of K + ‐evoked [ 3 H]‐noradrenaline release from rat and human brain slices by gabapentin: involvement of KATP channels. Naunyn Schmiedebergs Arch Pharmacol 363: 537–542.
7. Fu J, Ji HL, Naren AP, Kirk KL (2001). A cluster of negative charges at the amino terminal tail of CFTR regulates ATP‐dependent channel gating. J Physiol 536: 459–470.
8. Hilgemann DW, Ball R (1996). Regulation of cardiac Na +,Ca 2+ exchange and KATP potassium channels by PIP2. Science 273: 956–959.
9. Huang CL, Feng S, Hilgemann DW (1998). Direct activation of inward rectifier potassium channels by PIP 2 and its stabilization by Gbetagamma. Nature 391: 803–806.
10. Huang CW, Huang CC, Liu YC, Wu SN (2004). Inhibitory effect of lamotrigine on A‐type potassium current in hippocampal neuron‐derived H19‐7 cells. Epilepsia 45: 729–736.
11. Huang CW, Huang CC, Wu SN (2006). The opening effect of pregabalin on ATP‐sensitive potassium channels in differentiated hippocampal neuron‐derived H19‐7 cells. Epilepsia 47: 720–726.
12. Huang CW, Huang CC, Wu SN (2007). Activation by zonisamide, a newer antiepileptic drug, of large‐conductance calcium‐activated potassium channel in differentiated hippocampal neuron‐derived H19‐7 cells. J Pharmacol Exp Ther 321: 98–106.
13. Kenna S, Roper J, Ho K, Hebert S, Ashcroft SJ, Ashcroft FM (1994). Differential expression of the inwardly‐rectifying K‐channel ROMK1 in rat brain. Brain Res Mol Brain Res 24: 353–356.
14. Kiehn J, Karle C, Thomas D, Yao X, Brachmann J, Kubler W (1998). HERG potassium channel activation is shifted by phorbol esters via protein kinase A‐dependent pathways. J Biol Chem 273: 25285–25291.
15. Kobayashi T, Ikeda K, Kumanishi T (2000). Inhibition by various antipsychotic drugs of the G‐protein‐activated inwardly rectifying K + (GIRK) channels expressed in Xenopus oocytes. Br J Pharmacol 129: 1716–1722.
16. Kobayashi T, Nishizawa D, Iwamura T, Ikeda K (2007). Inhibition by cocaine of G protein‐activated inwardly rectifying K + channels expressed in Xenopus oocytes. Toxicol In Vitro 21: 656–664.
17. Kobayashi T, Washiyama K, Ikeda K (2004). Inhibition of G protein‐activated inwardly rectifying K + channels by various antidepressant drugs. Neuropsychopharmacology 29: 1841–1851.
18. Kobayashi T, Washiyama K, Ikeda K (2006). Inhibition of G protein‐activated inwardly rectifying K + channels by ifenprodil. Neuropsychopharmacology 31: 516–524.
19. Kuzniecky R, Ho S, Pan J, Martin R, Gilliam F, Faught E et al. (2002). Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 58: 368–372.
20. Leung YM, Zeng WZ, Liou HH, Solaro CR, Huang CL (2000). Phosphatidylinositol 4,5‐bisphosphate and intracellular pH regulate the ROMK1 potassium channel via separate but interrelated mechanisms. J Biol Chem 275: 10182–10189.
21. Levitan IB (1994). Modulation of ion channels by protein phosphorylation and dephosphorylation. Annu Rev Physiol 56: 193–212.
22. Lindberger M, Luhr O, Johannessen SI, Larsson S, Tomson T (2003). Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study. Ther Drug Monit 25: 457–462.
23. Liou HH, Zhou SS, Huang CL (1999). Regulation of ROMK1 channel by protein kinase A via a phosphatidylinositol 4,5‐bisphosphate‐dependent mechanism. Proc Natl Acad Sci USA 96: 5820–5825.
24. Liu B, Jia Z, Geng X, Bei J, Zhao Z, Jia Q et al. (2007). Selective inhibition of Kir currents by antihistamines. Eur J Pharmacol 558: 21–26.
25. Madeja M, Margineanu DG, Gorji A, Siep E, Boerrigter P, Klitgaard H et al. (2003). Reduction of voltage‐operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action ? Neuropharmacology 45: 661–671.
26. McClelland D, Evans RM, Barkworth L, Martin DJ, Scott RH (2004). A study comparing the actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG neurones from neonatal rats. BMC Pharmacol 4: 14.
27. McNicholas CM, MacGregor GG, Islas LD, Yang Y, Hebert SC, Giebisch G (1998). pH‐dependent modulation of the cloned renal K + channel, ROMK. Am J Physiol Renal Physiol 275: F972–F981.
28. McNicholas CM, Wang W, Ho K, Hebert SC, Giebisch G (1994). Regulation of ROMK1 K + channel activity involves phosphorylation processes. Proc Natl Acad Sci USA 91: 8077–8081.
29. Mixcoatl‐Zecuatl T, Medina‐Santillan R, Reyes‐Garcia G, Vidal‐Cantu GC, Granados‐Soto V (2004). Effect of K + channel modulators on the antiallodynic effect of gabapentin. Eur J Pharmacol 484: 201–208.
30. Murbartian J, Lei Q, Sando JJ, Bayliss DA (2005). Sequential phosphorylation mediates receptor‐ and kinase‐induced inhibition of TREK‐1 background potassium channels. J Biol Chem 280: 30175–30184.
31. Nadeau H, McKinney S, Anderson DJ, Lester HA (2000). ROMK1 (Kir1.1) causes apoptosis and chronic silencing of hippocampal neurons. J Neurophysiol 84: 1062–1075.
32. Neusch C, Weishaupt JH, Bähr M (2003). Kir channels in the CNS: emerging new roles and implications for neurological diseases. Cell Tissue Res 311: 131–138.
33. Ng GY, Bertrand S, Sullivan R, Ethier N, Wang J, Yergey J et al. (2001). Gamma‐aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol Pharmacol 59: 144–152.
34. Perry PJ, Miller DD, Arndt SV, Cadoret RJ (1991). Clozapine and norclozapine plasma concentrations and clinical response of treatment‐refractory schizophrenic patients. Am J Psychiatry 148: 231–235.
35. Reimann F, Ashcroft FM (1999). Inwardly rectifying potassium channels. Curr Opin Cell Biol 11: 503–508.
36. Rice AS, Maton S (2001). Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 94: 215–224.
37. Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP et al. (1998). A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 29: 233–249.
38. Thomas D, Wendt‐Nordahl G, Rockl K, Ficker E, Brown AM, Kiehn J (2001). High‐affinity blockade of human ether‐a‐go‐go‐related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL‐32872. J Pharmacol Exp Ther 297: 753–761.
39. Vazquez‐Lopez A, Sierra‐Paredes G, Sierra‐Marcuno G (2005). Role of cAMP‐dependent protein kinase on acute picrotoxin‐induced seizures. Neurochem Res 30: 613–618.
40. Voets T, Droogmans G, Nilius B (1996). Membrane currents and the resting membrane potential in cultured bovine pulmonary artery endothelial cells. J Physiol 497: 95–107.
41. Wuttke TV, Seebohm G, Bail S, Maljevic S, Lerche H (2005). The new anticonvulsant retigabine favors voltage‐dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol Pharmacol 67: 1009–1017.
42. Xiong ZQ, Saggau P, Stringer JL (2000). Activity‐dependent intracellular acidification correlates with the duration of seizure activity. J Neurosci 20: 1290–1296.
43. Xu ZC, Yang Y, Hebert SC (1996). Phosphorylation of the ATP‐sensitive, inwardly rectifying K + channel, ROMK, by cyclic AMP‐dependent protein kinase. J Biol Chem 271: 9313–9319.
44. Yechikhov S, Morenkov E, Chulanova T, Godukhin O, Shchipakina T (2001). Involvement of cAMP‐ and Ca 2+ /calmodulin‐dependent neuronal protein phosphorylation in mechanisms underlying genetic predisposition to audiogenic seizures in rats. Epilepsy Res 46: 15–25.
45. Yokoyama N, Mori N, Kumashiro H (1989). Chemical kindling induced by cAMP and transfer to electrical kindling. Brain Res 492: 158–162.
46. Zeng WZ, Liou HH, Krishna UM, Falck JR, Huang CL (2002). Structural determinants and specificities for ROMK1‐phosphoinositide interaction. Am J Physiol Renal Physiol 282: F826–F834.
47. Zona C, Tancredi V, Longone P, D'Arcangelo G, D'Antuono M, Manfredi M et al. (2002). Neocortical potassium currents are enhanced by the antiepileptic drug lamotrigine. Epilepsia 47: 685–690.